Pharmaceuticals and Clinical Research converge at the forefront of medical innovation, intertwining to advance healthcare through scientific inquiry and evidence-based practices. The pharmaceutical industry is the engine driving drug discovery, development, and production, aiming to deliver safe and effective medications to address diverse health needs.
Clinical research plays a pivotal role in this journey, conducting systematic investigations to assess the safety, efficacy, and real-world impact of pharmaceutical interventions. Rigorous clinical trials, involving human participants, form the backbone of this research, generating data that informs healthcare decisions and regulatory approvals.
Pharmaceuticals and Clinical Research collectively contribute to the evolution of personalized medicine, tailoring treatments to individual patient characteristics. This dynamic relationship fosters the discovery of novel therapeutic agents, from small molecules to biologics, ushering in an era of targeted and precision medicine.
Pharmaceuticals and Clinical Research are inseparable partners, navigating the complex terrain of medical science to enhance patient outcomes, elevate standards of care, and shape the future of medicine.
Vladlen Slepak
University of Miami School of Medicine, United States
Axel H Schonthal
University of Southern California, United States
Bernd Blobel
University of Regensburg, Germany
Consolato M Sergi
University of Alberta, Canada
Luis Jesus Villarreal Gomez
Universidad Autónoma de Baja California, Mexico
Lan Wang
Paretor LLC, United States
Maria Cristina Gamberini
University of Modena and Reggio Emilia, Italy
Lucas Amaral Machado
University of Sao Paulo State – UNESP, Brazil
Saad Tayyab
UCSI University, Malaysia
Anil Pareek
Anand Pharmacy College, IndiaSubmit your abstract Today
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada